These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9510195

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
    Errington F, Bateman A, Kottke T, Thompson J, Harrington K, Merrick A, Hatfield P, Selby P, Vile R, Melcher A.
    Clin Cancer Res; 2006 Feb 15; 12(4):1333-41. PubMed ID: 16489091
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice.
    Kircheis R, Küpcü Z, Wallner G, Rössler V, Schweighoffer T, Wagner E.
    Cancer Gene Ther; 2000 Jun 15; 7(6):870-8. PubMed ID: 10880017
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells.
    Koppenhagen FJ, Küpcü Z, Wallner G, Crommelin DJ, Wagner E, Storm G, Kircheis R.
    Clin Cancer Res; 1998 Aug 15; 4(8):1881-6. PubMed ID: 9717815
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
    Kim TS, Xu WS, Sun T, Cohen EP.
    Melanoma Res; 1995 Aug 15; 5(4):217-27. PubMed ID: 7496156
    [Abstract] [Full Text] [Related]

  • 33. Generation of tumor-specific cytotoxic T lymphocyte and prolongation of the survival of tumor-bearing mice using interleukin-18-secreting fibroblasts loaded with an epitope peptide.
    Chung SW, Cohen EP, Kim TS.
    Vaccine; 2004 Jun 30; 22(20):2547-57. PubMed ID: 15193380
    [Abstract] [Full Text] [Related]

  • 34. New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice.
    O-Sullivan I, Chopra A, Kim TS, Magnuson S, Falduto MT, Huang J, Cohen EP.
    Cancer Gene Ther; 2007 Apr 30; 14(4):389-98. PubMed ID: 17273183
    [Abstract] [Full Text] [Related]

  • 35. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization.
    Irvine AS, Trinder PK, Laughton DL, Ketteringham H, McDermott RH, Reid SC, Haines AM, Amir A, Husain R, Doshi R, Young LS, Mountain A.
    Nat Biotechnol; 2000 Dec 30; 18(12):1273-8. PubMed ID: 11101806
    [Abstract] [Full Text] [Related]

  • 36. Expression of a transfected H-2Kb gene in B16 cells correlates with suppression of liver metastases in triple immunodeficient mice.
    Calorini L, Marozzi A, Byers HR, Waneck GL, Lee KW, Isselbacher KJ, Gattoni-Celli S.
    Cancer Res; 1992 Jul 15; 52(14):4036-41. PubMed ID: 1617680
    [Abstract] [Full Text] [Related]

  • 37. Tumor immunity in mice immunized with fibroblasts transfected with tumor DNA.
    de Zoeten EF, Li D, Cohen EP.
    Adv Exp Med Biol; 2001 Jul 15; 495():393-401. PubMed ID: 11774600
    [No Abstract] [Full Text] [Related]

  • 38. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
    Björkdahl O, Dohlsten M, Sjögren HO.
    Cancer Gene Ther; 2000 Oct 15; 7(10):1365-74. PubMed ID: 11059695
    [Abstract] [Full Text] [Related]

  • 39. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J, Lil GW, Sui YF, Sun YJ, Huang YY, Si SY, Ge W, Song HP.
    Hepatogastroenterology; 2007 Oct 15; 54(75):681-7. PubMed ID: 17591041
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S, Nagai H, Horikawa T, Furukawa J, Belladonna ML, Yoshimoto T, Hara I, Nishigori C.
    Cancer Res; 2006 Jun 15; 66(12):6395-404. PubMed ID: 16778218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.